Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1511-1520 of 2862 for cancer

Edit search filters
  1. Study To Evaluate The Safety And Effectiveness Of Axicabtagene Ciloleucel In Combination With Utomilumab In Adults With Relapsed/Refractory Large B-cell Lymphoma

    Rochester, MN

  2. DALY II USA/ MB-CART2019.1 For DLBCL

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  3. Stereotactic Radiosurgery or Whole-Brain Radiation Therapy in Treating Patients with Brain Metastases that have been Removed by Surgery

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. Radiation Therapy With Or Without Temozolomide In Treating Patients With Anaplastic Glioma

    Jacksonville, FL, Rochester, MN

  5. A Study Of KRN23 In Adult Subjects With Tumor-Induced Osteomalacia Or Epidermal Nevus Syndrome

    Rochester, MN

  6. A Study To Evaluate Tacrolimus/Methotrexate Versus Post-Transplant Cyclophosphamide/ Tacrolimus/Mycophenolate Mofetil In Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation

    Jacksonville, FL, Rochester, MN

  7. Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma

    Scottsdale/Phoenix, AZ

  8. DNA Sequencing-Based Monitoring Of Minimal Residual Disease To Predict Relapse In Aggressive B-cell Non-Hodgkin Lymphomas

    Rochester, MN

  9. A Study Of Four-Dimensional MRI For Image-Guided Radiation Therapy

    Scottsdale/Phoenix, AZ

  10. Comparison Of F-18 FDG And C-11 Acetate PET In Multiple Myeloma

    Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer